Why the study?
Does the C-reactive protein/albumin ratio predict no-reflow in STEMI patients treated with primary PCI?
Population
1217 consecutive ST-elevation myocardial infarction patients who achieved epicardial vessel patency with…
Comparison
C-reactive protein/albumin ratio measured from… vs Patients with reflow vs no-reflow
Design
Cohort
Authors
Loading...
CAR may aid no-reflow risk stratification in STEMI; hypothesis-generating and should not yet change practice.
Does the C-reactive protein/albumin ratio predict no-reflow in STEMI patients treated with primary PCI?
The C-reactive protein/albumin ratio measured on admission is an independent predictor of no-reflow in STEMI patients undergoing primary PCI, outperforming individual markers.
Karabağ et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: